Prysmian (PRY IM) CEO says the group sees no signs of significant delays or cancellations in demand from hyperscalers and data centres
Newsquawk Staff ·
Prysmian (PRY IM) CEO says the group sees no signs of significant delays or cancellations in demand from hyperscalers and data centres.
What it means
Management commentary of this kind tends to matter less for what it says about the company itself than for what it signals along the AI infrastructure capex chain. Cable and grid equipment suppliers sit downstream of hyperscaler spending decisions, so order book and demand read-throughs from this corner of the market have been treated as confirmation or contradiction of the broader data centre buildout thesis, and prior episodes of demand reassessment have tended to surface first through exactly this type of supplier commentary before appearing in hyperscaler capex guidance itself. The relevant distinction is between delays, which shift revenue timing across quarters, and cancellations, which cut the book outright; the denial addresses both but leaves open the softer risks of project phasing, price renegotiation, and capacity constraint rather than demand constraint. Prysmian's prior form is that of a primary beneficiary of electrification and grid spending, so commentary from its chief executive carries more weight on sector direction than a peripheral supplier's would. Follow-ons worth noting are peer commentary from the cable and electrical equipment complex, the next round of hyperscaler capex disclosures, and any change in order intake or backlog disclosure at results. As unquantified verbal reassurance, the content is directional rather than a print.
- Newsquawk Daily European Equity Opening News - 29th October 2026
- BBVA (BBVA SM) Q3 (EUR) net 3.02bln (exp. 2.98bln), NII 8.08bln (exp. 7.77bln)
- Salzgitter (SZG GY) 9M (EUR): Sales 7.3bln, Adj. EBITDA 659mln; FY sales view 10bln (exp. 9.64bln), FY adj. EBITDA view 800-875mln
- Campari (CPR IM) Q3 2026 (EUR): Revenue 777mln (exp. 769mln); confirm FY26 guidance of circa +3% organic topline growth
- Novo Nordisk (NOVOB DC) to present new liver data across Wegovy 2.4mg and investigational efruxifermin at The Liver Meeting 2026
Related headlines
- Stellantis (STLAM IM) earnings call summary: Co. firmly believes will beat initial goal of EUR 2.4bln cost savings in 202719 hours ago
- Mercedes-Benz Group (MBG GY) CEO says the Co. is preparing a broader strategy update covering 2030 and beyond, with China remaining a core pillar of its long-term plans20 hours ago
- Epiroc (EPIA SS) Q3 2026 (SEK): Revenue 16.8bln (exp. 17.4bln), Orders 17.5bln (exp. 17.8bln), Adj. EBIT 3.43bln (exp. 3.49bln)21 hours ago
- Orion (ORNBV FH) Q3 2026 (EUR): Sales 542.2mln (exp. 546.7mln). Raises its FY26 Net sales guidance to 2.07-2.14bln (prev. guided 2-2.1bln)22 hours ago
- EUROPEAN MOVERS: Standard Chartered (STAN LN) +4.5%, Deutsche Bank (DBK GY) +3.3%, BASF (BAS GY) +0.9%, Danone (BN FP) +0.9%, BNP Paribas (BNP FP) U/C, Santander (SAN SM) -3.2%, GSK (GSK LN) -4.8%23 hours ago
- EUROPEAN OPEN: SKHY surges after Q3 profits; EQNR NO lifts FY production view; UBSG SW Q3 net income miss; DBK GY posts third straight record profit; MBG GY Q3 revenue & earnings fall; ULVR LN raises FY volume growth view; GSK LN Q3 profit & revenue beat23 hours ago
- Additional European Equity News - 28th October 20261 day ago
- European pre-market summary - 28th October 2026: Tech leads after SK Hynix results1 day ago
- Newsquawk Daily European Equity Opening News - 28th October 20261 day ago
- Intesa Sanpaolo (ISP IM) receives ECB approval for its Monte dei Paschi (BMPS IM) bid 1 day ago
- Saint Gobain (SGO FP) Q3 2026 (EUR): Sales 11.6bln (exp. 11.6bln)1 day ago
- ASM International NV (ASM NA) Q3 2026 (EUR): Adj. net income 315.4mln, Revenue 1.16bln (exp. 1.11bln)1 day ago
- Eni (ENI IM) CEO says it is too early to seek additional partners for Venezuela's Perla gas field1 day ago
- Nokian Tyres (TYRES FH) Q3 2026 (EUR): Sales 359.1mln (exp. 374.8mln), Segment EBIT 47mln (exp. 41.7mln)1 day ago
- Mercedes-Benz Group (MBG GY) lowers FY26 Mercedes-Benz Cars adj. return on sales guidance to 2-3% (prev. guided 3-5%) and now expects Group EBIT to be flat Y/Y (prev. guided significantly higher Y/Y)1 day ago